Sonja Zweegman

Also affiliated with Vrije Universiteit Amsterdam

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

2in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 5 papers. Top paper: “The characteristics, treatment patterns, and outcomes of older adults aged 80 and over with multiple myeloma”.

The characteristics, treatment patterns, and outcomes of older adults aged 80 and over with multiple myeloma

Journal of Geriatric Oncology(2020)10.1016/j.jgo.2020.03.005

N/A

0.449DataRank · unranked

19 citations

Nicole Foley, Sonja Zweegman, Ravi Vij, Tanya M. Wildes, Mark A. Fiala

Iberdomide plus low-dose cyclophosphamide and dexamethasone in patients with relapsed and refractory multiple myeloma (the ICON study): a multicentre, single-arm, phase 2 trial

The Lancet Haematology(2026)10.1016/s2352-3026(25)00298-4

N/A

0.208DataRank · unranked

3 citations

Wouter Plattel, Elizabeth A de Kort, Febe Smits, Alexandra J Croockewit, Mark-David Levin +18 more

A phase 2 multicentre study of siltuximab, an anti-interleukin-6 monoclonal antibody, in patients with relapsed or refractory multiple myeloma

UNC Libraries(2020)10.17615/tmgg-w910

N/A

0DataRank · unranked

0 citations

Suzanne Lentzsch, Pieter Sonneveld, Sonja Zweegman, Hong Xie, Xiang Qin +13 more

High immunoproteasome and low constitutive proteasome subunit levels correlate with sensitivity to bortezomib-containing chemotherapy: update from the Children’s Oncology Group AALL1231 trial

Haematologica(2025)10.3324/haematol.2024.286171

N/A

0DataRank · unranked

0 citations

Johan van Meerloo, Suzanne N. van Dijk, Zinia J. Kwidama, Gaye Jenkins, David T. Teachey +8 more

Supplementary Figure 1 from Monocytes and Granulocytes Reduce CD38 Expression Levels on Myeloma Cells in Patients Treated with Daratumumab

10.1158/1078-0432.22462589

N/A

0DataRank · unranked

0 citations

Kris A. Frerichs, Inger S. Nijhof, Berris van Kessel, Jeroen F. van Velzen, Andries C. Bloem +13 more